Edmonton Journal

Concordia said to seek deal to slash debt load

Drugmaker pursuing restructur­ing plan with creditors after losses top $1 billion

- ALLISON MCNEELY

TORONTO Concordia Internatio­nal Corp., the drugmaker that won court protection from creditors last week as it negotiates a debt restructur­ing, is seeking to strike a deal to cut its debt load within the next few weeks.

The company had the consent of creditor advisers to pursue the court protection and will seek to reach an agreement within four weeks, according to a person with knowledge of the matter, who asked not to be identified because the talks are private. Options being explored include a debt exchange in which creditors would swap their obligation­s for equity or new debt.

The company said last week it also hasn’t ruled out a filing under Chapter 11 in the U.S. or the Companies’ Creditors Arrangemen­t Act, the closest Canadian equivalent to the American bankruptcy law.

The pharmaceut­ical company, weighed down by US$3.7 billion in debt, announced Friday it’s pursuing a restructur­ing plan with its creditors under the Canada Business Corporatio­ns Act after it opted not to pay an interest payment and the maturity on a bridge loan due this month to preserve cash. Concordia was granted creditor protection until further notice by an Ontario court, which prevents its creditors from pushing it into default or pursuing other remedies to get their money back.

A representa­tive for Oakville, Ont.-based Concordia declined to comment.

Concordia will require a majority of the holders representi­ng two-thirds of the value of each stakeholde­r class to approve its restructur­ing plan under CBCA, according to Stephanie Ben-Ishai, a professor at York University’s Osgoode Hall Law School. The company will also require final sign-off from an Ontario judge.

Restructur­ing under CBCA allows Concordia to restructur­e without filing under Chapter 11 or the Companies’ Creditors Arrangemen­t Act. It’s an interpreta­tion of a Canadian corporate law that has expanded over the past decade to include restructur­ing, Ben-Ishai said.

“It’s another option in the toolbox for reorganizi­ng a company that might be near insolvent but solvent,” she said by phone from Toronto. “It is often used to target restructur­ing the balance sheet in less time, less court interventi­on, less profession­al costs, and also avoiding the stigma of bankruptcy.”

Concordia’s debtholder­s could file a motion to have the creditor protection lifted in order to pursue other remedies or course of action if they find that the negotiatio­ns are taking too long, according to Brian Pawluck, an independen­t restructur­ing and insolvency specialist.

Concordia hired advisers Perella Weinberg Partners and Skadden, Arps, Slate, Meagher & Flom LLP earlier this year to explore strategic alternativ­es, including a restructur­ing, after months of deteriorat­ing liquidity and mounting interest payments. The company hired Goodmans LLP as its Canadian counsel.

A representa­tive for Perella declined to comment. A representa­tive for Skadden didn’t comment. A call to Goodmans with a request for comment wasn’t immediatel­y returned.

The company hasn’t posted an annual profit since 2014, with losses so far this year topping US$1 billion. Discussion­s with lenders, who also hired advisers, began this summer and are ongoing, according to a company filing.

Concordia has about US$340 million of cash on hand and intends to pay any obligation­s on its secured debt and its trade and employee obligation­s, according to a filing. It has payments on its secured term loans due in December.

Bennett Jones LLP, Paul, Weiss, Rifkind, Wharton & Garrison LLP, and Ashurst LLP are representi­ng the unsecured debtholder committee, according to a filing. Osler, Hoskin & Harcourt LLP and White & Case LLP are representi­ng secured debtholder­s.

A representa­tive for Ashurst declined to comment and representa­tives for the other firms didn’t comment.

It’s another option in the toolbox for reorganizi­ng a company that might be near insolvent but solvent.

 ?? GETTY IMAGES/ISTOCKPHOT­O FILES ?? Drugmaker Concordia is mulling options after months of deteriorat­ing liquidity and interest payments.
GETTY IMAGES/ISTOCKPHOT­O FILES Drugmaker Concordia is mulling options after months of deteriorat­ing liquidity and interest payments.

Newspapers in English

Newspapers from Canada